Keyphrases
Parkinson's Disease
100%
Positron Emission Tomography
36%
Huntington's Disease
34%
Dystonia
29%
Nonhuman Primate
22%
Levodopa
18%
Striatal
18%
Cervical Dystonia
17%
Radioligand
17%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
15%
Parkinsonism
15%
Deep Brain Stimulation
14%
Vesicular Acetylcholine Transporter (VAChT)
13%
Radiotracer
12%
Idiopathic Parkinson's Disease
12%
D2 Receptor
12%
Receptor Binding
12%
Dopamine
12%
Age of Onset
12%
Striatum
11%
Regional Cerebral Blood Flow (rCBF)
11%
Alpha-synuclein (α-syn)
10%
Parkinson Patients
10%
Baboon
9%
Dopamine D2 Receptor (DRD2)
9%
Sphingosine-1-phosphate Receptor (S1PR)
8%
Pathophysiology
8%
Premanifest Huntington's Disease
8%
Radiosynthesis
8%
Blood Flow
8%
Dementia
8%
Blepharospasm
8%
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
8%
Flow Response
7%
Subthalamic nucleus
7%
Basal Ganglia
7%
Alzheimer's Disease
7%
Movement Disorders
7%
Unified Parkinson's Disease Rating Scale (UPDRS)
7%
Putamen
7%
D2-like
7%
Rodents
6%
Macaque
6%
Functional Connectivity
6%
Neurodegenerative Diseases
6%
Striatal Dopamine
6%
Gait
6%
Tremor
6%
Cerebral Blood Flow
6%
Neuroimaging
6%
Neuroscience
Parkinson's Disease
98%
Positron Emission Tomography
41%
Dystonia
32%
Fluorine-18
29%
In Vivo
21%
Positron Emission Tomography
20%
Huntington's Disease
20%
Electrical Brain Stimulation
19%
L-DOPA
18%
Receptor
17%
Parkinsonism
17%
Radioligand
16%
Subthalamic Nucleus
16%
Tremor
14%
Spasmodic torticollis
12%
Dopaminergic
12%
In Vitro
12%
Receptor Binding
11%
Putamen
10%
Vesicular Acetylcholine Transporter
9%
Striatum
9%
Alzheimer's Disease
8%
Stereotypic Movement Disorder
8%
Tetrahydropyridine
8%
Dopamine Receptor D2
7%
Synuclein
7%
Functional Connectivity
7%
Magnetic Resonance Imaging
7%
Basal Ganglia
6%
Sphingosine-1-Phosphate Receptor
6%
Familial Parkinson's Disease
6%
Metabolic Pathway
6%
Cerebellum
6%
Amyloid Protein
6%
Behavior (Neuroscience)
6%
Dopamine Receptor D3
5%
Haplotype
5%
Neurodegenerative Disorder
5%
Resting-State Functional Connectivity
5%